[Pulmonary arterial hypertension. Physiopathology, genetic aspects and response to the chronic use of sildenafil]

Arq Bras Cardiol. 2005 Aug;85(2):147-54. doi: 10.1590/s0066-782x2005001500015. Epub 2005 Aug 18.
[Article in Portuguese]
No abstract available

Publication types

  • Review

MeSH terms

  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiopathology
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Hypertension, Pulmonary* / genetics
  • Hypertension, Pulmonary* / physiopathology
  • Pedigree
  • Phosphodiesterase Inhibitors / therapeutic use
  • Piperazines / therapeutic use
  • Pulmonary Artery / physiopathology
  • Purines
  • Sildenafil Citrate
  • Sulfones
  • Vasodilator Agents / therapeutic use

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate